Morphoceuticals is a techbio company focused on understanding and reprogramming the body’s bioelectrome to induce tissue regeneration and treat disease. It builds tools and insights around the bioelectric networks that connect cells to organs, aiming to guide tissue repair and organ regeneration. The company emphasizes multi-omics, bioelectric profiling, and ion-channel modulation to influence regenerative outcomes, with headquarters in Medford, Massachusetts. Their mission centers on translating bioelectrome research into regenerative therapies and health improvements.
No recent news for this company.
No recent deals for this company.